RX INNOVATIONS LTD

Registered Number: 16216869

England and Wales

Unaudited Financial Statements

for the period ended 31 January 2026

for

RX INNOVATIONS LTD

RX INNOVATIONS LTD

Statement of Financial Position

As at 31 January 2026

	£	2026 £
Current assets	86,221
Creditors: amount falling due within one year	(29,799)
Net current assets/(liabilities)		56,422
Total assets less current liabilities		56,422
Net assets/(liabilities)		56,422


Capital and reserves		56,422

For the period ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

---------------------------------------------

Callum Richard John Butcher
Director

Date approved: 15 May 2026

RX INNOVATIONS LTD

Notes to the Accounts

For the period ended 31 Jan 2026

Statutory Information

Rx Innovations Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 16216869, registration address Rx Innovations Ltd Unit A, 82 James Carter Road, Mildenhall, IP28 7DE, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the period was 1.